2009至2016年澳大利亚男性低危前列腺癌保守管理趋势:基于人群队列研究
该研究基于澳大利亚维多利亚州前列腺癌结局登记(PCOR-Vic)中2009年1月至2016年12月诊断的3201例低危前列腺癌男性,评估保守管理(诊断后12个月内无积极治疗)趋势。结果显示保守管理比例从2009年52%升至2016年73%(p<0.001),主要归因于主动监测从33%升至67%(p<0.001)。多因素分析中,年龄增加、较低前列腺特异性抗原和临床分期、较低社会经济地位及在公立都市机构诊断均与保守管理可能性更高独立相关。
要点
- 3201例低危前列腺癌中60%(1928/3201)接受保守管理,52%(1664/3201)记录为主动监测。
- 保守管理从2009年52%升至2016年73%(p<0.001),主动监测从33%升至67%(p<0.001)。
- 年龄<60岁者保守管理从37%升至66%,年龄≥70岁者从72%升至86%。
核心结论
- 澳大利亚低危前列腺癌保守管理 uptake 增加,与国际指南及其他国际人群研究一致。
研究设计与样本
- 基于澳大利亚维多利亚州前列腺癌结局登记(PCOR-Vic)的人群队列研究,纳入2009年1月至2016年12月诊断的3201例低危前列腺癌男性。
主要发现
- 3201例中60%(1928/3201)接受保守管理,52%(1664/3201)记录为主动监测。
- 保守管理从2009年52%升至2016年73%(p<0.001),主动监测从33%升至67%(p<0.001)。
- 年龄<60岁者保守管理从37%升至66%,年龄≥70岁者从72%升至86%。
- 多因素分析中,年龄增加、较低前列腺特异性抗原和临床分期、较低社会经济地位及在公立都市机构诊断均与保守管理可能性更高独立相关。
临床怎么用
- 识别社会人口学和机构实践差异有助于制定针对性策略以改善低危前列腺癌男性管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Conservative management, specifically with active surveillance (AS), has emerged as the preferred approach for low-risk prostate cancer (LRPC). We evaluated the trend for conservative management (ie, no active treatment within 12mo of diagnosis) for LRPC in an Australian population-based cohort of men captured in the Prostate Cancer Outcomes Registry Victoria (PCOR-Vic). Of the 3201 men diagnosed with LRPC between January 2009 and December 2016, 60% (1928/3201) had conservative management, and 52% (1664/3201) were documented to be on AS. There was an increase in conservative management from 52% in 2009 to 73% in 2016 (p<0.001), largely attributable to an increase in AS from 33% in 2009 to 67% in 2016 (p<0.001). When stratified by age group, the increase in conservative management was more pronounced among younger patients: from 37% to 66% for men aged <60yr versus from 72% to 86% for men aged ≥70yr. In multivariable analyses, increasing age, lower prostate-specific antigen and clinical category, lower socioeconomic status, and being diagnosed in public metropolitan institutions were all independently associated with a greater likelihood of conservative management. Identification of sociodemographic and institutional variations in practice allows for targeted strategies to improve management for men with LRPC. PATIENT SUMMARY: We looked at the uptake of conservative management (no active treatment within 12 mo of diagnosis) over time in an Australian population-based cohort of men with low-risk prostate cancer. The proportion of men with low-risk prostate cancer managed conservatively increased from 52% in 2009 to 73% in 2016. The increase in the uptake of conservative management for low-risk prostate cancer in Australia is concordant with international guidelines and other international population-based studies.
引用
- Ong WL, Evans SM, Evans M, et al. Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016. Eur Urol Oncol. 2019. PMID: 31411964. doi:10.1016/j.euo.2019.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。